Page last updated: 2024-11-03

propranolol and Brain Inflammation

propranolol has been researched along with Brain Inflammation in 6 studies

Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.

Research Excerpts

ExcerptRelevanceReference
"Propranolol treatment abrogated the elaboration of inflammatory cytokine mRNA expression in the brain instigated in our model, having no treatment effects in non-DFP exposed groups."1.62The β-adrenergic receptor blocker and anti-inflammatory drug propranolol mitigates brain cytokine expression in a long-term model of Gulf War Illness. ( Kelly, KA; Michalovicz, LT; Miller, DB; O'Callaghan, JP; Sullivan, K, 2021)

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19902 (33.33)18.7374
1990's2 (33.33)18.2507
2000's1 (16.67)29.6817
2010's0 (0.00)24.3611
2020's1 (16.67)2.80

Authors

AuthorsStudies
Michalovicz, LT1
Kelly, KA1
Miller, DB1
Sullivan, K1
O'Callaghan, JP1
Ichiyama, T1
Sakai, T1
Catania, A1
Barsh, GS1
Furukawa, S1
Lipton, JM1
Renton, KW1
Nicholson, TE1
Schreier, HA1
Abraham, G1
Jarrett, F1
Richert, JR1
Potolicchio, S1
Garagusi, VF1
Manz, HJ1
Cohan, SL1
Hartmann, DP1
Johnson, RT1

Other Studies

6 other studies available for propranolol and Brain Inflammation

ArticleYear
The β-adrenergic receptor blocker and anti-inflammatory drug propranolol mitigates brain cytokine expression in a long-term model of Gulf War Illness.
    Life sciences, 2021, Nov-15, Volume: 285

    Topics: Adrenergic beta-Antagonists; Animals; Anti-Inflammatory Agents, Non-Steroidal; Brain; Corticosterone

2021
Inhibition of peripheral NF-kappaB activation by central action of alpha-melanocyte-stimulating hormone.
    Journal of neuroimmunology, 1999, Oct-29, Volume: 99, Issue:2

    Topics: Acute Disease; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; alpha-MSH; Animals; Atenol

1999
Hepatic and central nervous system cytochrome P450 are down-regulated during lipopolysaccharide-evoked localized inflammation in brain.
    The Journal of pharmacology and experimental therapeutics, 2000, Volume: 294, Issue:2

    Topics: Adrenergic beta-Antagonists; Animals; Autonomic Nerve Block; Brain; Cytochrome P-450 CYP1A1; Cytochr

2000
Use of propranolol in the treatment of postencephalitic psychosis.
    The American journal of psychiatry, 1979, Volume: 136, Issue:6

    Topics: Child; Encephalitis; Humans; Male; Neurocognitive Disorders; Orientation; Propranolol; Psychomotor A

1979
Propranolol in the treatment of postencephalitic psychosis.
    Canadian journal of psychiatry. Revue canadienne de psychiatrie, 1990, Volume: 35, Issue:1

    Topics: Adolescent; Aggression; Encephalitis; Female; Humans; Neurocognitive Disorders; Propranolol

1990
Cytomegalovirus encephalitis associated with episodic neurologic deficits and OKT-8+ pleocytosis.
    Neurology, 1987, Volume: 37, Issue:1

    Topics: Adult; Cytomegalovirus Infections; Electroencephalography; Encephalitis; Humans; Lymphocytosis; Male

1987